HCPCS 2021

M1003 Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy
Added on: Tuesday, January 01, 2019
Status changed on: Tuesday, January 01, 2019
BETOS Classification : Undefined codes
Medicare coverage status:Carrier judgment